A Retrospective Analysis of Recurrent Intracranial Ependymoma

被引:34
作者
Antony, Reuben [1 ]
Wong, Kenneth E. [2 ]
Patel, Moneil [3 ]
Olch, Arthur J. [2 ]
McComb, Gordon [4 ]
Krieger, Mark [4 ]
Gilles, Floyd [3 ]
Sposto, Richard [5 ]
Erdreich-Epstein, Anat [1 ]
Dhall, Girish [1 ]
Gardner, Sharon [6 ]
Finlay, Jonathan L. [1 ]
机构
[1] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Radiat Oncol Program, Los Angeles, CA 90027 USA
[3] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90027 USA
[4] Childrens Hosp Los Angeles, Dept Neurosurg, Los Angeles, CA 90027 USA
[5] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
[6] NYU, Med Ctr, Stephen D Hassenfeld Childrens Ctr Canc & Blood D, New York, NY 10016 USA
关键词
medulloblastoma; subgroups; genomics; pre-diagnostic interval; pediatric brain tumor; PROGNOSTIC-FACTORS; CHILDREN; SURVIVAL; CHEMOTHERAPY; CHILDHOOD; IRRADIATION; PATTERNS; SOCIETY; TRIAL;
D O I
10.1002/pbc.24996
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Children presenting with medulloblastoma have a wide range of initial presenting symptoms. However, the influence of underlying tumor biology on the initial presentation of medulloblastoma is currently unknown. In light of the recent discovery of distinct medulloblastoma subgroups, we sought to define the initial presentation of childhood medulloblastoma in a subgroup specific manner. Procedure We assembled a cohort of 126 medulloblastoma cases at the Hospital for Sick Children between 1994 and 2012 and determined subgroup affiliation using nanoString. Clinical details pertaining to the initial presentation were determined through a retrospective chart review. Results The median pre-diagnostic interval across all medulloblastoma cases was 4 weeks (IQR: 4-12 weeks). Strikingly, when the pre-diagnostic interval was then determined in a subgroup specific manner, cases with WNT and Group 4 tumors showed significantly longer median pre-diagnostic intervals of 8 weeks compared to 2 weeks for SHH and 4 weeks for Group 3 (P = 0.0001). Younger age was significantly associated with a prolonged pre-diagnostic interval (P = 0.02 for all). When stratifying by subgroup the association with age was only significant in Group 4 (P = 0.04 for Group 4). Improved survival was significantly associated with a longer pre-diagnostic interval (P = 0.02), however is no longer significant when controlling for subgroup (P = 0.07). Conclusions The duration of the pre-diagnostic interval in childhood medulloblastoma is highly subgroup dependent, further highlighting the clinical heterogeneity and biological relevance of the four principle subgroups of medulloblastoma. Pediatr Blood Cancer 2014;61:1190-1194. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:1195 / 1201
页数:7
相关论文
共 21 条
[11]   Relapsed intracranial ependymoma in children in the UK: Patterns of relapse, survival and therapeutic outcome [J].
Messahel, B. ;
Ashley, S. ;
Saran, F. ;
Ellison, D. ;
Ironside, J. ;
Phipps, K. ;
Cox, T. ;
Chong, W. K. ;
Robinson, K. ;
Picton, S. ;
Pinkerton, C. R. ;
Mallucci, C. ;
Macarthur, D. ;
Jaspan, T. ;
Michalski, A. ;
Grundy, R. G. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (10) :1815-1823
[12]  
Perilongo G, 1997, MED PEDIATR ONCOL, V29, P79
[13]   INTRACRANIAL EPENDYMOMAS OF CHILDHOOD - LONG-TERM OUTCOME AND PROGNOSTIC FACTORS [J].
POLLACK, IF ;
GERSZTEN, PC ;
MARTINEZ, AJ ;
LO, KH ;
SHULTZ, B ;
ALBRIGHT, AL ;
JANOSKY, J ;
DEUTSCH, M .
NEUROSURGERY, 1995, 37 (04) :655-666
[14]   Disseminated ependymomas of the central nervous system [J].
Rezai, A ;
Woo, HH ;
Lee, M ;
Cohen, H ;
Zagzag, D ;
Epstein, FJ .
JOURNAL OF NEUROSURGERY, 1996, 85 (04) :618-624
[15]   Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group [J].
Robertson, PL ;
Zeltzer, PM ;
Boyett, JM ;
Rorke, LB ;
Allen, JC ;
Geyer, JR ;
Stanley, P ;
Li, H ;
Albright, AL ;
McGuire-Cullen, P ;
Finlay, JL ;
Stevens, KR ;
Milstein, JM ;
Packer, RJ ;
Wisoff, J .
JOURNAL OF NEUROSURGERY, 1998, 88 (04) :695-703
[16]   TREATMENT OF INTRACRANIAL EPENDYMOMAS OF CHILDREN - REVIEW OF A 15-YEAR EXPERIENCE [J].
ROUSSEAU, P ;
HABRAND, JL ;
SARRAZIN, D ;
KALIFA, C ;
TERRIERLACOMBE, MJ ;
REKACEWICZ, C ;
REY, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (02) :381-386
[17]   The history of ependymoma management [J].
Shim, Kyu-Won ;
Kim, Dong-Seok ;
Choi, Joong-Uhn .
CHILDS NERVOUS SYSTEM, 2009, 25 (10) :1167-1183
[18]   PROGNOSTIC FACTORS IN CHILDHOOD EPENDYMOMAS [J].
SUTTON, LN ;
GOLDWEIN, J ;
PERILONGO, G ;
LANG, B ;
SCHUT, L ;
RORKE, L ;
PACKER, R .
PEDIATRIC NEUROSURGERY, 1991, 16 (02) :57-65
[19]   The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors [J].
Tihan, Tarik ;
Zhou, Tianni ;
Holmes, Emi ;
Burger, Peter C. ;
Ozuysal, Sema ;
Rushing, Elisabeth J. .
MODERN PATHOLOGY, 2008, 21 (02) :165-177
[20]   Intracranial ependymomas in childhood: recurrence, reoperation, and outcome [J].
Vinchon, M ;
Leblond, P ;
Noudel, R ;
Dhellemmes, P .
CHILDS NERVOUS SYSTEM, 2005, 21 (03) :221-226